Nystatin and Blepharitis - a phase IV clinical study of FDA data

Summary:

Blepharitis is reported as a side effect among people who take Nystatin (nystatin), especially for people who are female, 60+ old, also take Prilosec, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Blepharitis when taking Nystatin. It is created by eHealthMe based on reports of 33,189 people who have side effects when taking Nystatin from the FDA, and is updated regularly.

What is Nystatin?

Nystatin has active ingredients of nystatin. It is often used in thrush. eHealthMe is studying from 33,567 Nystatin users. Check the latest studies of Nystatin.

What is Blepharitis?

Blepharitis (chronic inflammation of the eyelid) is found to be associated with 512 drugs and 690 conditions by eHealthMe. Check the latest studies of Blepharitis.

On Jul, 24, 2026

33,189 people reported to have side effects when taking Nystatin.
Among them, 20 people (0.06%) have Blepharitis.

Among these 20 people:

What is the gender of people who have Blepharitis when taking Nystatin? *

female: 95 %
male: 5 %

What is the age of people who have Blepharitis when taking Nystatin? *

What are other drugs people take besides Nystatin? *

What are other side effects people have besides Blepharitis? *

Weakness: 12 people, 60.00%
Pain: 11 people, 55.00%
Stress And Anxiety: 10 people, 50.00%
Anaemia (lack of blood): 9 people, 45.00%
Conjunctivitis (pink eye): 9 people, 45.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 40.00%
Chest Pain: 8 people, 40.00%
Injury: 8 people, 40.00%
Dehydration (dryness resulting from the removal of water): 8 people, 40.00%
Osteoporosis (bones weak and more likely to break): 7 people, 35.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.00%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 5.00%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 5.00%
High Blood Pressure: 1 person, 5.00%
Heart Rate Irregular: 1 person, 5.00%
Cardiac Failure Congestive: 1 person, 5.00%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 1 person, 5.00%
Atrial Tachycardia (rhythm disturbance that arises in the atria): 1 person, 5.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nystatin and have Blepharitis?

- Check whether Blepharitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nystatin:

Nystatin (33,567 reports)

Blepharitis treatments and more:

Blepharitis (5,399 reports)

Browse all side effects of Nystatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blepharitis:

Blepharitis (512 drugs)

Browse all the conditions that are associated with Blepharitis:

Blepharitis (690 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nystatin (the active ingredients of Nystatin) and Nystatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.